Background: Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies.
Appropriate treatment requires an accurate diagnosis and is influenced by coexisting …

The objective of this study is to summarize the clinical and pathologic characteristics of
malignant struma ovarii to facilitate the early diagnosis and treatment of this disease. All 144 …

Purpose Struma ovarii is rare, accounting for 0.3–1% of ovarian tumours. Malignant
transformation may occur, most often into papillary thyroid carcinoma. There is a paucity of …

Background: Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies.
Appropriate treatment requires an accurate diagnosis and is influenced by coexisting …

Background Malignant struma ovarii (MSO) is a unique type of ovarian malignancy that data
on the survival outcome is limited and management strategy remains controversial due to its …

Introduction: Malignant struma ovarii (MSO) is a rare thyroid cancer arising within an ovarian
teratoma. While surgical excision of the primary tumor is widely accepted as standard of …

Purpose To present a case of struma ovarii with a typical features and synchronous primary
thyroid carcinoma and review the available literature to guide diagnosis and management of …

Purpose Struma ovarii is a highly specialized teratoma consisting primarily of mature thyroid
tissue. However, malignant struma ovarii coexisting with thyroid carcinoma, not to mention …

Thyroid carcinoma originating in struma ovarii comprises a small minority of all cases of
struma ovarii. Given the rarity of this diagnosis, literature to guide evaluation and …

Introduction: Struma ovarii accounts for 2% of mature teratomas. Struma ovarii is diagnosed
when thyroid tissue accounts for> 50% of the teratoma. Malignant transformation is rare …